Aspirin as a therapeutic agent in cardiovascular disease. Special Writing Group.
Why the study?
Does aspirin prevent cardiovascular disease in primary and secondary prevention settings?
Population
Patients at risk for or with cardiovascular disease (primary and secondary prevention)
Design
Guideline
Authors
Discussion
Loading...
Member takes
Implication
Guides aspirin use in primary and secondary CVD prevention; extends prior statements with updated evidence synthesis.
Structured PICO
Does aspirin prevent cardiovascular disease in primary and secondary prevention settings?
P
Population
Patients at risk for or with cardiovascular disease (primary and secondary prevention)
I
Intervention
Aspirin
This AHA position statement provides guidelines for the use of aspirin in the primary and secondary prevention of cardiovascular disease.
Cite This Study
Fuster et al. (1993) studied this question.